Markets.com Logo
markets.com

CELV

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

CELV.US represents Caladrius Biosciences Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies designed to reverse, not manage, disease. Their primary focus is on autoimmune and select other diseases. The company's clinical programs involve using patients' own cells to fight diseases, aiming to provide durable, disease-modifying therapies.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: CELV.US's revenue, earnings, and growth prospects significantly impact its stock price. Strong financials typically lead to a higher stock valuation.

Industry Trends: The overall health and performance of the biotechnology industry can influence investor sentiment toward CELV.US. Positive industry trends can boost the stock.

Regulatory Approvals: Any regulatory approvals or rejections for CELV.US's products or therapies can dramatically affect the stock price. Approvals usually lead to a surge.

Clinical Trial Results: Data from clinical trials is crucial. Positive trial outcomes can drive the stock price up, while negative results can cause a significant drop.

Market Conditions: Broad market factors like economic growth, inflation, and interest rates can influence investor risk appetite and affect the demand for CELV.US's stock.

Competition: The competitive landscape within the biotech sector can impact CELV.US. New products or therapies from competitors might negatively affect investor perception.

News and Events: Major news announcements, partnerships, acquisitions, or significant company events related to CELV.US can create volatility in its stock price.

Investor Sentiment: Overall investor sentiment and market psychology towards CELV.US can influence its stock price. Positive sentiment can drive up demand.

Analyst Ratings: Recommendations and price targets from financial analysts can influence investor decisions and impact the stock's price movement.

Intellectual Property: The strength and protection of CELV.US's intellectual property, such as patents, can affect its long-term value and thus stock price.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com